BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20592280)

  • 1. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
    Wixler V; Hirner S; Müller JM; Gullotti L; Will C; Kirfel J; Günther T; Schneider H; Bosserhoff A; Schorle H; Park J; Schüle R; Buettner R
    J Cell Biol; 2007 Apr; 177(1):163-72. PubMed ID: 17420295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells.
    Bénard A; Boué J; Chapey E; Jaume M; Gomes B; Dietrich G
    J Neuroimmunol; 2008 Jun; 197(1):21-8. PubMed ID: 18486241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.
    Yanagihara S; Komura E; Nagafune J; Watarai H; Yamaguchi Y
    J Immunol; 1998 Sep; 161(6):3096-102. PubMed ID: 9743376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration.
    Rathinasamy A; Czeloth N; Pabst O; Förster R; Bernhardt G
    J Immunol; 2010 Oct; 185(7):4072-81. PubMed ID: 20826749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.
    Iijima N; Yanagawa Y; Clingan JM; Onoé K
    Int Immunol; 2005 Sep; 17(9):1201-12. PubMed ID: 16027136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
    Gollmann G; Neuwirt H; Tripp CH; Mueller H; Konwalinka G; Heufler C; Romani N; Tiefenthaler M
    Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.
    Walker SR; Ogagan PD; DeAlmeida D; Aboka AM; Barksdale EM
    J Pediatr Surg; 2006 Jan; 41(1):260-5. PubMed ID: 16410144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
    Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
    Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4.
    Ricart BG; John B; Lee D; Hunter CA; Hammer DA
    J Immunol; 2011 Jan; 186(1):53-61. PubMed ID: 21106854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired intestinal wound healing in Fhl2-deficient mice is due to disturbed collagen metabolism.
    Kirfel J; Pantelis D; Kabba M; Kahl P; Röper A; Kalff JC; Buettner R
    Exp Cell Res; 2008 Dec; 314(20):3684-91. PubMed ID: 18950620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.
    Jeannin P; Magistrelli G; Herbault N; Goetsch L; Godefroy S; Charbonnier P; Gonzalez A; Delneste Y
    Eur J Immunol; 2003 Feb; 33(2):326-33. PubMed ID: 12548563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav1 regulates the migration and adhesion of dendritic cells.
    Spurrell DR; Luckashenak NA; Minney DC; Chaplin A; Penninger JM; Liwski RS; Clements JL; West KA
    J Immunol; 2009 Jul; 183(1):310-8. PubMed ID: 19542442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
    Park J; Will C; Martin B; Gullotti L; Friedrichs N; Buettner R; Schneider H; Ludwig S; Wixler V
    FASEB J; 2008 Jul; 22(7):2508-20. PubMed ID: 18356303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.